Evaluation of the overall IFN-γ and IL-17 pro-inflammatory responses after DNA therapy of tuberculosis

References

• Svenson S, Källenius G, Pawlowski A, Hamasur B. Towards new tuberculosis vaccines. Hum Vaccin 2010; 6:309 - 17; http://dx.doi.org/10.4161/hv.6.4.10711; PMID: 20372087
   PubMed Web of Science ®Google Scholar
• Global Tuberculosis Control WHO. WHO Report 2010. WHO 2010.
   Google Scholar
• Churchyard GJ, Kaplan G, Fallows D, Wallis RS, Onyebujoh P, Rook GA. Advances in immunotherapy for tuberculosis treatment. [ix.] Clin Chest Med 2009; 30:769 - 82, ix; http://dx.doi.org/10.1016/j.ccm.2009.08.009; PMID: 19925966
   PubMed Web of Science ®Google Scholar
• Ma Z, Lienhardt C, McIlleron H, Nunn AJ, Wang X. Global tuberculosis drug development pipeline: the need and the reality. Lancet 2010; 375:2100 - 9; http://dx.doi.org/10.1016/S0140-6736(10)60359-9; PMID: 20488518
   PubMed Web of Science ®Google Scholar
• de Paula L, Silva CL, Carlos D, Matias-Peres C, Sorgi CA, Soares EG, et al. Comparison of different delivery systems of DNA vaccination for the induction of protection against tuberculosis in mice and guinea pigs. Genet Vaccines Ther 2007; 5:2; http://dx.doi.org/10.1186/1479-0556-5-2; PMID: 17250766
   PubMedGoogle Scholar
• dos Santos SA, Zárate-Bladés CR, de Sá Galetti FC, Brandão IT, Masson AP, Soares EG, et al. A subunit vaccine based on biodegradable microspheres carrying rHsp65 protein and KLK protects BALB/c mice against tuberculosis infection. Hum Vaccin 2010; 6:1047 - 53; http://dx.doi.org/10.4161/hv.6.12.13350; PMID: 21157178
   PubMed Web of Science ®Google Scholar
• Souza PR, Zárate-Bladés CR, Hori JI, Ramos SG, Lima DS, Schneider T, et al. Protective efficacy of different strategies employing Mycobacterium leprae heat-shock protein 65 against tuberculosis. Expert Opin Biol Ther 2008; 8:1255 - 64; http://dx.doi.org/10.1517/14712598.8.9.1255; PMID: 18694348
   PubMed Web of Science ®Google Scholar
• Bonato VL, Gonçalves ED, Soares EG, Santos Júnior RR, Sartori A, Coelho-Castelo AA, et al. Immune regulatory effect of pHSP65 DNA therapy in pulmonary tuberculosis: activation of CD8+ cells, interferon-gamma recovery and reduction of lung injury. Immunology 2004; 113:130 - 8; http://dx.doi.org/10.1111/j.1365-2567.2004.01931.x; PMID: 15312144
   PubMed Web of Science ®Google Scholar
• Nuermberger E, Tyagi S, Williams KN, Rosenthal I, Bishai WR, Grosset JH. Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model. Am J Respir Crit Care Med 2005; 172:1452 - 6; http://dx.doi.org/10.1164/rccm.200507-1047OC; PMID: 16151038
   PubMed Web of Science ®Google Scholar
• Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, et al. Novel therapeutic vaccine: granulysin and new DNA vaccine against Tuberculosis. Hum Vaccin 2011; 7:Suppl 60 - 7; http://dx.doi.org/10.4161/hv.7.0.14563; PMID: 21546794
   PubMed Web of Science ®Google Scholar
• Zárate-Bladés CR, Bonato VL, da Silveira EL, Oliveira e Paula M, Junta CM, Sandrin-Garcia P, et al. Comprehensive gene expression profiling in lungs of mice infected with Mycobacterium tuberculosis following DNAhsp65 immunotherapy. J Gene Med 2009; 11:66 - 78; http://dx.doi.org/10.1002/jgm.1269; PMID: 19035575
   PubMed Web of Science ®Google Scholar
• Rook GA, Lowrie DB, Hernàndez-Pando R. Immunotherapeutics for tuberculosis in experimental animals: is there a common pathway activated by effective protocols?. J Infect Dis 2007; 196:191 - 8; http://dx.doi.org/10.1086/518937; PMID: 17570105
   PubMed Web of Science ®Google Scholar
• Ernst JD. The immunological life cycle of tuberculosis. Nat Rev Immunol 2012; 12:581 - 91; http://dx.doi.org/10.1038/nri3259; PMID: 22790178
   PubMed Web of Science ®Google Scholar
• Kaufmann SH. Tuberculosis vaccine development: strength lies in tenacity. Trends Immunol 2012; 33:373 - 9; http://dx.doi.org/10.1016/j.it.2012.03.004; PMID: 22560865
   PubMed Web of Science ®Google Scholar
• Grange JM, Brunet LR, Rieder HL. Immune protection against tuberculosis--when is immunotherapy preferable to vaccination?. Tuberculosis (Edinb) 2011; 91:179 - 85; http://dx.doi.org/10.1016/j.tube.2010.12.004; PMID: 21233019
   PubMed Web of Science ®Google Scholar
• Doherty TM. Immunotherapy for TB. Immunotherapy 2012; 4:629 - 47; http://dx.doi.org/10.2217/imt.12.52; PMID: 22788130
   PubMed Web of Science ®Google Scholar
• Gupta UD, Katoch VM. Animal models of tuberculosis. Tuberculosis (Edinb) 2005; 85:277 - 93; http://dx.doi.org/10.1016/j.tube.2005.08.008; PMID: 16249122
   PubMed Web of Science ®Google Scholar
• Ly LH, McMurray DN. Tuberculosis: vaccines in the pipeline. Expert Rev Vaccines 2008; 7:635 - 50; http://dx.doi.org/10.1586/14760584.7.5.635; PMID: 18564018
   PubMed Web of Science ®Google Scholar
• Prabowo SA, Gröschel MI, Schmidt ED, Skrahina A, Mihaescu T, Hastürk S, et al. Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines. Med Microbiol Immunol 2012; In Press http://dx.doi.org/10.1007/s00430-012-0278-6; PMID: 23143437
   PubMed Web of Science ®Google Scholar
• Stanford J, Stanford C, Grange J. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis. Front Biosci 2004; 9:1701 - 19; http://dx.doi.org/10.2741/1292; PMID: 14977580
   PubMed Web of Science ®Google Scholar
• Vilaplana C, Montané E, Pinto S, Barriocanal AM, Domenech G, Torres F, et al. Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI. Vaccine 2010; 28:1106 - 16; http://dx.doi.org/10.1016/j.vaccine.2009.09.134; PMID: 19853680
   PubMed Web of Science ®Google Scholar
• Dlugovitzky D, Notario R, Martinel-Lamas D, Fiorenza G, Farroni M, Bogue C, et al. Immunotherapy with oral, heat-killed, Mycobacterium vaccae in patients with moderate to advanced pulmonary tuberculosis. Immunotherapy 2010; 2:159 - 69; http://dx.doi.org/10.2217/imt.09.90; PMID: 20635925
   PubMed Web of Science ®Google Scholar
• Jenkins PA, Campbell IA, Banks J, Gelder CM, Prescott RJ, Smith AP. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. Thorax 2008; 63:627 - 34; http://dx.doi.org/10.1136/thx.2007.087999; PMID: 18250184
   PubMed Web of Science ®Google Scholar
• Vilaplana C, Gil O, Cáceres N, Pinto S, Díaz J, Cardona PJ. Prophylactic effect of a therapeutic vaccine against TB based on fragments of Mycobacterium tuberculosis.. PLoS One 2011; 6:e20404; http://dx.doi.org/10.1371/journal.pone.0020404; PMID: 21647222
   PubMed Web of Science ®Google Scholar
• Lowrie DB, Tascon RE, Bonato VL, Lima VM, Faccioli LH, Stavropoulos E, et al. Therapy of tuberculosis in mice by DNA vaccination. Nature 1999; 400:269 - 71; http://dx.doi.org/10.1038/22326; PMID: 10421369
   PubMed Web of Science ®Google Scholar
• Ha SJ, Jeon BY, Youn JI, Kim SC, Cho SN, Sung YC. Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis.. Gene Ther 2005; 12:634 - 8; http://dx.doi.org/10.1038/sj.gt.3302465; PMID: 15690060
   PubMed Web of Science ®Google Scholar
• Henao-Tamayo M, Palaniswamy GS, Smith EE, Shanley CA, Wang B, Orme IM, et al. Post-exposure vaccination against Mycobacterium tuberculosis.. Tuberculosis (Edinb) 2009; 89:142 - 8; http://dx.doi.org/10.1016/j.tube.2009.01.002; PMID: 19264552
   PubMed Web of Science ®Google Scholar
• Aagaard C, Hoang T, Dietrich J, Cardona PJ, Izzo A, Dolganov G, et al. A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat Med 2011; 17:189 - 94; http://dx.doi.org/10.1038/nm.2285; PMID: 21258338
   PubMed Web of Science ®Google Scholar
• Ahn SS, Jeon BY, Kim KS, Kwack JY, Lee EG, Park KS, et al. Mtb32 is a promising tuberculosis antigen for DNA vaccination in pre- and post-exposure mouse models. Gene Ther 2012; 19:570 - 5; http://dx.doi.org/10.1038/gt.2011.140; PMID: 21956689
   PubMed Web of Science ®Google Scholar
• Yang XY, Chen QF, Li YP, Wu SM. Mycobacterium vaccae as adjuvant therapy to anti-tuberculosis chemotherapy in never-treated tuberculosis patients: a meta-analysis. PLoS One 2011; 6:e23826; http://dx.doi.org/10.1371/journal.pone.0023826; PMID: 21909406
   PubMed Web of Science ®Google Scholar
• Guo S, Zhao J. Immunotherapy for tuberculosis: what’s the better choice?. Front Biosci 2012; 17:2684 - 90; http://dx.doi.org/10.2741/4079; PMID: 22652806
   PubMed Web of Science ®Google Scholar
• Lockhart E, Green AM, Flynn JL. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 2006; 177:4662 - 9; PMID: 16982905
   PubMed Web of Science ®Google Scholar
• Bafica A, Scanga CA, Feng CG, Leifer C, Cheever A, Sher A. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis.. J Exp Med 2005; 202:1715 - 24; http://dx.doi.org/10.1084/jem.20051782; PMID: 16365150
   PubMed Web of Science ®Google Scholar
• Jung YJ, Ryan L, LaCourse R, North RJ. Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice. J Exp Med 2005; 201:1915 - 24; http://dx.doi.org/10.1084/jem.20050265; PMID: 15955839
   PubMed Web of Science ®Google Scholar
• Arriaga AK, Orozco EH, Aguilar LD, Rook GA, Hernández Pando R. Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis. Clin Exp Immunol 2002; 128:229 - 37; http://dx.doi.org/10.1046/j.1365-2249.2002.01832.x; PMID: 11985512
   PubMed Web of Science ®Google Scholar
• Morais Fonseca D, Rosada RS, e Paula MO, Wowk PF, Franco LH, Soares EG, et al. Experimental tuberculosis: designing a better model to test vaccines against tuberculosis. Tuberculosis (Edinb) 2010; 90:135 - 42; http://dx.doi.org/10.1016/j.tube.2010.01.005; PMID: 20188631
   PubMed Web of Science ®Google Scholar
• Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993; 178:2243 - 7; http://dx.doi.org/10.1084/jem.178.6.2243; PMID: 8245795
   PubMed Web of Science ®Google Scholar
• Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178:2249 - 54; http://dx.doi.org/10.1084/jem.178.6.2249; PMID: 7504064
   PubMed Web of Science ®Google Scholar
• Philips JA, Ernst JD. Tuberculosis pathogenesis and immunity. Annu Rev Pathol 2012; 7:353 - 84; http://dx.doi.org/10.1146/annurev-pathol-011811-132458; PMID: 22054143
   PubMed Web of Science ®Google Scholar
• Jurado JO, Pasquinelli V, Alvarez IB, Peña D, Rovetta AI, Tateosian NL, et al. IL-17 and IFN-γ expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease. J Leukoc Biol 2012; 91:991 - 1002; http://dx.doi.org/10.1189/jlb.1211619; PMID: 22416258
   PubMed Web of Science ®Google Scholar
• Cruz A, Fraga AG, Fountain JJ, Rangel-Moreno J, Torrado E, Saraiva M, et al. Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis.. J Exp Med 2010; 207:1609 - 16; http://dx.doi.org/10.1084/jem.20100265; PMID: 20624887
   PubMed Web of Science ®Google Scholar
• Cruz A, Khader SA, Torrado E, Fraga A, Pearl JE, Pedrosa J, et al. Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J Immunol 2006; 177:1416 - 20; PMID: 16849446
   PubMed Web of Science ®Google Scholar
• Torrado E, Cooper AM. IL-17 and Th17 cells in tuberculosis. Cytokine Growth Factor Rev 2010; 21:455 - 62; http://dx.doi.org/10.1016/j.cytogfr.2010.10.004; PMID: 21075039
   PubMed Web of Science ®Google Scholar
• Dietrich J, Aagaard C, Leah R, Olsen AW, Stryhn A, Doherty TM, et al. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. J Immunol 2005; 174:6332 - 9; PMID: 15879133
   PubMed Web of Science ®Google Scholar
• Hervas-Stubbs S, Majlessi L, Simsova M, Morova J, Rojas MJ, Nouzé C, et al. High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection. Infect Immun 2006; 74:3396 - 407; http://dx.doi.org/10.1128/IAI.02086-05; PMID: 16714570
   PubMed Web of Science ®Google Scholar
• Romano M, Roupie V, Wang XM, Denis O, Jurion F, Adnet PY, et al. Immunogenicity and protective efficacy of tuberculosis DNA vaccines combining mycolyl-transferase Ag85A and phosphate transport receptor PstS-3. Immunology 2006; 118:321 - 32; http://dx.doi.org/10.1111/j.1365-2567.2006.02373.x; PMID: 16827893
   PubMed Web of Science ®Google Scholar
• Sable SB, Cheruvu M, Nandakumar S, Sharma S, Bandyopadhyay K, Kellar KL, et al. Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination. PLoS One 2011; 6:e22718; http://dx.doi.org/10.1371/journal.pone.0022718; PMID: 21799939
   PubMed Web of Science ®Google Scholar
• Cervantes-Villagrana AR, Hernández-Pando R, Biragyn A, Castañeda-Delgado J, Bodogai M, Martínez-Fierro M, et al. Prime-boost BCG vaccination with DNA vaccines based in β-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model. Vaccine 2013; 31:676 - 84; http://dx.doi.org/10.1016/j.vaccine.2012.11.042; PMID: 23196205
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4:330 - 6; http://dx.doi.org/10.1038/ni904; PMID: 12612578
   PubMed Web of Science ®Google Scholar
• Ribeiro-Rodrigues R, Resende Co T, Rojas R, Toossi Z, Dietze R, Boom WH, et al. A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis. Clin Exp Immunol 2006; 144:25 - 34; http://dx.doi.org/10.1111/j.1365-2249.2006.03027.x; PMID: 16542361
   PubMed Web of Science ®Google Scholar
• Chen X, Zhou B, Li M, Deng Q, Wu X, Le X, et al. CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin Immunol 2007; 123:50 - 9; http://dx.doi.org/10.1016/j.clim.2006.11.009; PMID: 17234458
   PubMed Web of Science ®Google Scholar
• Fedatto PF, Sérgio CA, Paula MO, Gembre AF, Franco LH, Wowk PF, et al. Protection conferred by heterologous vaccination against tuberculosis is dependent on the ratio of CD4(+) /CD4(+) Foxp3(+) cells. Immunology 2012; 137:239 - 48; http://dx.doi.org/10.1111/imm.12006; PMID: 22891805
   PubMed Web of Science ®Google Scholar
• Kaufmann SH, Väth U, Thole JE, Van Embden JD, Emmrich F. Enumeration of T cells reactive with Mycobacterium tuberculosis organisms and specific for the recombinant mycobacterial 64-kDa protein. Eur J Immunol 1987; 17:351 - 7; http://dx.doi.org/10.1002/eji.1830170308; PMID: 3106059
   PubMed Web of Science ®Google Scholar
• Antas PR, Cardoso FL, Pereira KC, Franken KL, Cunha KS, Klatser P, et al. T cell immune responses to mycobacterial antigens in Brazilian tuberculosis patients and controls. Trans R Soc Trop Med Hyg 2005; 99:699 - 707; http://dx.doi.org/10.1016/j.trstmh.2005.05.002; PMID: 15993451
   PubMed Web of Science ®Google Scholar
• Leyten EM, Lin MY, Franken KL, Friggen AH, Prins C, van Meijgaarden KE, et al. Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis.. Microbes Infect 2006; 8:2052 - 60; http://dx.doi.org/10.1016/j.micinf.2006.03.018; PMID: 16931093
   PubMed Web of Science ®Google Scholar
• Chegou NN, Black GF, Loxton AG, Stanley K, Essone PN, Klein MR, et al. Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting. BMC Infect Dis 2012; 12:10; http://dx.doi.org/10.1186/1471-2334-12-10; PMID: 22260319
   PubMed Web of Science ®Google Scholar
• Parida SK, Kaufmann SH. The quest for biomarkers in tuberculosis. Drug Discov Today 2010; 15:148 - 57; http://dx.doi.org/10.1016/j.drudis.2009.10.005; PMID: 19854295
   PubMed Web of Science ®Google Scholar
• Brandes M, Willimann K, Moser B. Professional antigen-presentation function by human gammadelta T Cells. Science 2005; 309:264 - 8; http://dx.doi.org/10.1126/science.1110267; PMID: 15933162
   PubMed Web of Science ®Google Scholar
• Casetti R, Agrati C, Wallace M, Sacchi A, Martini F, Martino A, et al. Cutting edge: TGF-beta1 and IL-15 Induce FOXP3+ gammadelta regulatory T cells in the presence of antigen stimulation. J Immunol 2009; 183:3574 - 7; http://dx.doi.org/10.4049/jimmunol.0901334; PMID: 19710458
   PubMed Web of Science ®Google Scholar
• Davey MS, Lin CY, Roberts GW, Heuston S, Brown AC, Chess JA, et al. Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection. PLoS Pathog 2011; 7:e1002040; http://dx.doi.org/10.1371/journal.ppat.1002040; PMID: 21589907
   PubMed Web of Science ®Google Scholar
• Tuomela M, Stanescu I, Krohn K. Validation overview of bio-analytical methods. Gene Ther 2005; 12:Suppl 1 S131 - 8; http://dx.doi.org/10.1038/sj.gt.3302627; PMID: 16231045
   PubMed Web of Science ®Google Scholar
• Rosada RS, de la Torre LG, Frantz FG, Trombone AP, Zárate-Bladés CR, Fonseca DM, et al. Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes. BMC Immunol 2008; 9:38; http://dx.doi.org/10.1186/1471-2172-9-38; PMID: 18647414
   PubMed Web of Science ®Google Scholar
• Hsia CC, Hyde DM, Ochs M, Weibel ER, ATS/ERS Joint Task Force on Quantitative Assessment of Lung Structure. An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure. Am J Respir Crit Care Med 2010; 181:394 - 418; http://dx.doi.org/10.1164/rccm.200809-1522ST; PMID: 20130146
   PubMed Web of Science ®Google Scholar
• Cohen J. Infectious Disease. Approval of novel TB drug celebrated-with restraint. Science 2013; 339:130; http://dx.doi.org/10.1126/science.339.6116.130; PMID: 23307714
   PubMed Web of Science ®Google Scholar